🇺🇸 FDA
Patent

US 8193202

LIMK2 inhibitors, compositions comprising them, and methods of their use

granted A61PA61P25/00A61P25/28

Quick answer

US patent 8193202 (LIMK2 inhibitors, compositions comprising them, and methods of their use) held by LEXICON PHARMACEUTICALS, INC. expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
LEXICON PHARMACEUTICALS, INC.
Grant date
Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P25/00, A61P25/28, A61P27/02, A61P27/06